A role for immunoproteasome in the regulation of intestinal permeability has been previously suggested both in mice during water avoidance stress (WAS) and in patients with irritable bowel syndrome (IBS). Here, we provide evidence that the ubiquitin-proteasome system (UPS) contributes to the pathophysiology of IBS. Indeed, we report that colonic proteome is altered in WAS mice and that β2i subunit deficiency modifies the proteome response that is associated with a limitation of colonic hyperpermeability. Interestingly, we show specific alterations of proteins involved in UPS, mitochondrial and energy metabolism. We also report changes in the pattern of colonic ubiquitome in diarrhea-predominant IBS patients (IBS-D), and particularly a reduced expression of ubiquitinated proteins involved in the NF-κB inflammatory signaling pathway. All these data suggest that immunoproteasome targeting may represent a new therapeutic strategy for the treatment of IBS patients with increased intestinal permeability.
INTRODUCTION
Irritable bowel syndrome (IBS) is a functional gastrointestinal (GI) disorder that affects 5-20% of the general population in industrialized countries. 1, 2 It is characterized by chronic abdominal pain associated with diarrhea and/or constipation, bloating and urgency. 3 Recent studies have shown that IBS-associated symptoms, such as visceral hypersensitivity, low-grade inflammation or pain, may be linked to disturbances in intestinal barrier function. [4] [5] [6] [7] [8] [9] Alterations were observed in the expression and distribution of intestinal tight junctions (TJs), apical protein structures that control paracellular permeability. [10] [11] [12] Indeed, IBS patients with diarrheapredominant symptoms (IBS-D) exhibited an increased permeability both in colon 13 and jejunum 12 , and a reduced expression of several TJ proteins such as occludin, zonula occludens-1 (ZO-1) and claudin-1. 11, 12 Emerging evidence supports the concept of altered colonic ubiquitineproteasome system (UPS) in IBS patients that could be responsible of intestinal barrier dysfunction. Interestingly, occludin has been reported as a functional target of the E3 ubiquitinprotein ligase Itch 14 and we have previously shown that the low expression of occludin in the colonic mucosa of IBS patients was related to its higher degradation by UPS. 11 UPS is a major pathway of proteolysis in eukaryotic cells and may contribute to the regulation of many intestinal biological processes, such as inflammatory response, cell proliferation and apoptosis. 10, 15, 16 Targeted proteins by UPS are polyubiquitinated and then processed by the constitutive 20S proteasome, which comprises three catalytic subunits named β1, β2, and β5. In mammals, the exposure of cells to inflammatory cytokines such as IFN-γ or TNF-α leads to the formation of an immunoproteasome that can be distinguished from its constitutive homologue through assembly of the catalytic immunosubunits named LMP2 (β1i), 4 MECL-1 (β2i) and LMP7 (β5i). 17 It has been reported an increased expression of immunoproteasome subunits in intestinal epithelial cell lines stimulated by IFN-γ. 15, 16 In vivo, the immunosubunits β1i and β2i were strongly upregulated in colon tissues of IBS 10 and Crohn's disease (CD) patients, 15 but not in patients with ulcerative colitis. Proteasome inhibitors such as bortezomib, MG132 and PR-957 have been developed and have achieved success in preventing experimental colitis in mice. [18] [19] [20] Similar effects have been observed with mice deficient in subunit β5i. 19 More recently, we showed a link between proteasome and intestinal permeability in mice. In this latter study, both pharmacological immunoproteasome inhibition and β2i subunit deficiency limited colonic hyperpermeability and improved occludin expression. 21 To better understand the underlying mechanisms, we thus aimed (i) to evaluate the colonic proteome in wild-type and β2i immunoproteasome subunit knock-out (β2i -/-) mice during water avoidance stress (WAS) and (ii) to investigate the colonic expression of 49 ubiquitinated proteins in IBS-D patients. 
MATERIAL AND METHODS

Animals
Male C57Bl/6 knock-out mice for MECL1 gene (or β2i proteasome subunit) were a kind gift from Professors Marcus Groettrup and Mickael Basler of Konstanz University (Germany) with the permission of Professor John Monaco from Cincinnati University (Ohio). The protocol was approved by CENOMEXA, the Ethics Committee of Normandy for Animal Experimentation (acceptance number: N/04-11-12/27/11 -15) . In addition, all experiments were performed in accordance with relevant guidelines and regulations (Official Journal of the European Community L 358, 18/12/1986) and followed ARRIVE guidelines. 22 
Water avoidance stress
The water avoidance stress (WAS) is a murine model of chronic stress that induces several symptoms associated to IBS. In particular, WAS increased visceral sensibility, colonic motility, intestinal permeability, pro-inflammatory cytokine production and mast cell count. 21,23-25 After one week of acclimatization at 23°C (12-hour light-dark cycle; dark phase: 8:00 PM -8:00 AM), WAS model was performed during 1 hour per day during 10 consecutive days as previously described. 21 After the last WAS procedure, mice were euthanized. Colonic samples were either taken, washed with ice-cold PBS and immediately frozen until further analysis or immediately used to evaluate paracellular permeability.
Intestinal permeability
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Colonic permeability was evaluated by measuring paracellular flux of FITC-dextran (4 kDa) through colonic samples mounted in Ussing chambers as previously described. 26 Briefly, FITCdextran (5 mg/ml) was placed in the mucosal side. After 3 hours at 37°C, medium from the serosal side was removed and stored at -80°C. The fluorescence level of FITC-dextran was measured in 96-well black plate with spectrometer Chameleon V (excitation at 485 nm, emission at 535 nm; Hidex, Turku, Finland).
qRT-PCR
Mucosal total RNA was extracted from samples as previously described. 27 After reverse transcription of 1.5 µg total RNA into cDNA by using 200 units of SuperScript™ II Reverse (vol:vol) IPG buffer with pH 3-10 non-linear (GE Healthcare). The protein content was determined by using 2D Quant kit (GE Healthcare).
Comparative proteome analysis
Total protein extract (40 µg for silver staining or 500 µg for CBB G-250 staining) was used to rehydrate Immobiline DryStrip gels (pH 3-10 NL 18 cm; GE Healthcare). Proteins were resolved in the first dimension by isoelectric focusing for a total of 50 000 V-h by using the Ettan IPGphor 3 (GE Healthcare). After equilibration of the strips, the second dimension was performed on 8-16% polyacrylamide gradient gels (20 cm x 18 cm x 1 mm) and was run on an Ettan Daltsix vertical system (GE Healthcare). The 2D gels were silver-stained (PlusOne Silver Staining kit; GE Healthcare) for image analysis or dyed following the CBB G-250 staining method for mass spectrometric analysis. 28 
(i) 2D image Analysis
Silver stained gels were scanned with an ImageScanner II (GE Healthcare) previously calibrated by a greyscale marker (Kodak) and 2D images were captured with Labscan 6.00 software (GE Healthcare). Differential analysis was realized by using ImageMaster 2D Platinum v7.0 software (GE Healthcare) for spot detection, background subtraction, spot volume normalisation and differences in spot expression among the groups and/or each experiment. Each tissue sample was subjected to 2DE three times to minimize run-to-run variation, and each set of 8 three gels was compared by using ImageMaster to confirm the nonappearance of statistically differential spots within the set of gels. The most representative silver-staining gels (gel migration, spot definition, and spot number) of each sample (n=5 per group) was used to identify differential colonic protein expression. The expression level was determined by the relative volume of each spot in the gel and expressed as %volume, calculated as spot volume/Σvolumes of all spots resolved in the gel. Variations in abundance, corresponding to normalized spot volume, were calculated as the ratio of average values of %volume for each group. Only spots with a %volume variation >1.4 were included in analysis. Statistical differences between the groups were determined using ANOVA (significance level P values < 0.05).
(
ii) In-gel trypsin digestion and protein identification by LC-ESI-MS/MS
Protein spots of interest were manually excised from colloidal Coomassie blue-stained 2D gels and digested. Briefly, gel fragments were washed three times for 20 min in destaining solution containing 50% (v/v) methanol and 50 mM ammonium bicarbonate. The excised spots were then air-dried for 1 h, which was followed by in-gel digestion in 30 µL of a digestion buffer containing 50 mM ammonium bicarbonate and 6 ng/µL sequencing grade bovine trypsin (Roche Diagnostics, Meylan, France). After overnight digestion, the aliquots were treated with 50 % Full autoMS1 scans from 290 to 1700 m/z and autoMS2 from 59 to 1700 m/z were recorded. In every cycle, a maximum of 5 precursors sort by charge state (2+ preferred and single-charged ions excluded) were isolated and fragmented in the collision cell that was automatically adjusted depending on the m/z. Active exclusion of these precursors was enabled after 1 spectra within 0.13 min, and the absolute threshold for precursor selection was set to 1000 counts (relative threshold 0.001%). For protein identification, MS/MS peak lists were extracted and compared with the protein databases using the MASCOT Daemon version 2.4.0 (Matrix Science, London, UK) search engine. The MASCOT searches were performed in Mus musculus database as previously described. 30 Protein hits were automatically validated if they satisfied one of the following criteria: identification with at least two top ranking peptides (bold and red) each with a MASCOT score of more than 41 (P < 0.001), or at least two top ranking peptides (bold and red) each with a MASCOT score of more than 31 (P < 0.01). To evaluate false-positive rates, all the initial database searches were performed using the "decoy" option of MASCOT. 
Ubiquitome analysis
Expression of 49 ubiquitinated proteins was assessed using the commercially Proteome
Profiler TM Human Ubiquitin Array kit (R&D Systems, Abingdon, UK) according to the manufacturer's instructions. Briefly, 300 µg of colonic mucosal proteins were loaded on membranes previously coated with specific antibodies directed against ubiquitinated proteins.
After incubation of these membranes with specific buffers and wash steps, ubiquitinated proteins were detected using ECL reagents (GE Healthcare). Each spot was quantified by densitometry using ImageScanner III and ImageQuant TL software (GE Healthcare). Only spots with a %Vol variation ratio greater than 1.5 were considered relevant.
Gene ontology-based analysis
The PANTHER classification system (version 10.1, http://www.pantherdb.org) was used to categorize the identified proteins according to their molecular function and biological process.
To identify significantly enriched biological themes and functional groups in the list of identified proteins, functional annotation clustering analysis was performed using the DAVID Gene Ontology (GO) tool version 6.7 32 as previously described 30 with minor modifications: the reference dataset were Mus musculus or Homo sapiens, and P < 0.05 for Benjamini-Hochberg correction was considered significant.
Western blot analysis
20 µg of total protein extracts were separated by 4-20% SDS-PAGE gels and electrotransferred onto nitrocellulose membrane (GE Healthcare) as previously described. 28 with TBS-T, immunocomplexes were revealed by using ECL detection reagents (GE Healthcare). Protein bands were quantified by densitometry with ImageScanner III and ImageQuant TL software (GE Healthcare). The blot was stripped and reblotted with a mouse monoclonal antibody anti β actin (A5441, 1:5000; Sigma Aldrich) also used as a loading control.
Detection of carbonylated Proteins
Carbonylated proteins were detected and analyzed following derivatization of protein carbonyl groups with 2,4-dinitrophenylhydrazine (DNPH), using the OxyBlot kit (Millipore, Billerica, MA). Briefly, colonic proteins were incubated with DNPH for 15 min at room temperature to convert carbonyl to hydrazone derivatives. The samples were neutralized and applied on SDS-PAGE and transferred to nitrocellulose membranes. Immunodetection was performed with a primary antibody directed against dinitrophenylhydrazone.
Statistical analysis
Results were compared in GraphPad Prism 5.0 (GraphPad software Inc, San Diego, CA, USA)
by two-way ANOVA (stress x β2i -/-) with Bonferroni post-tests. To data from patients, t-test or Mann-Whitney test were used as appropriate. For all tests, P < 0.05 was considered significant.
RESULTS
Immunoproteasome subunit beta2i deficiency prevents hyperpermeability and proinflammatory cytokine production in the colonic tissue of stressed mice
The WAS model increased fecal pellet output from day 1 to day 10 both in wild-type (wt) and . These data confirm that WAS did not affect colonic permeability in β2i -/-mice, as previously described. 21 
WAS and immunoproteasome subunit beta2i deficiency alter colonic proteome in mice
To evaluate colonic proteome and then identify altered biological processes in wt and β2i /-mice both in control and WAS conditions, we used a proteomic approach combining 2DE mapping and mass spectrometry identification. Image analysis detected approximately 2100 protein spots per 2D gel, out of which 75% were successfully matched throughout all gels. Representative 2D gels from both conditions are shown in Figure 1A . Fifty protein spots were differentially and significantly expressed between the four mice groups (at least ± 1.4 fold change; two-way ANOVA, p<0.05). These protein spots were analyzed by using liquid chromatography coupled with electrospray ionization MS/MS, and 36 spots (72%) were identified (Table 1) . Overall, 33
non-redundant proteins were obtained. Indeed, two proteins, named MICOS complex subunit Mic60 (spots 2 and 4, Figure 1A ) and protein disulfide-isomerase precursor (spots 14, 16 and 17; Figure 1A ), were detected at multiple spot positions that could be due to protein isoforms, i.e.
difference in maturation state, degradation and/or post-translational modifications. Among the identified proteins, 22 proteins were downregulated in the colonic mucosa of wt WAS mice compared with wt mice, while only 6 proteins were affected by WAS in β2i -/-mice. Interestingly, among these 6 proteins, only 2 were downregulated. In addition, we also observed that 7 proteins were differentially expressed in β2i -/-WAS mice compared to wt WAS mice. In this latter case, proteasome subunit alpha type-3 (PSMA3), proteasome subunit alpha type-5 (PSAM5) and ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3) were up-regulated in the colonic mucosa of β2i -/-WAS mice (range from 2.20 to 3.80-fold), whereas proteasome subunit alpha type-4 (PSMA4), alpha-enloase 1 (ENO1), 60 kDa heat shock protein (HSP60) and glutamate dehydrogenase 1 (GDH1) showed a reduced expression (with fold changes from 1.48 to 1.86).
To validate the data from proteomics experiments, three proteins were randomly selected to verify the expression level via Western blot analysis ( Figure 2A ). The colonic expression levels of GDH1 and HSP60 were downregulated in β2i -/-WAS mice compared to wt WAS mice, whereas UCH-L3 expression was increased, which is consistent with the results given by 2-DE analysis, and thus confirmed the proteomic findings.
WAS and immunoproteasome subunit beta2i deficiency modify expression of protein involved in mitochondrial and energy metabolism in the colon
Panther Gene Ontology (GO) analysis allowed us to elucidate the different functions and processes in which the 33 proteins identified are putatively involved. According to the molecular function analysis ( Figure 1B) , most of the proteins were related with catalytic activity (53.1%) and binding (18.8%). Concerning biological processes, the identified proteins were mainly involved in metabolic process (45.5%, Figure 1B ). To expand the GO analysis, we next analyzed the proteomic data with DAVID functional annotation tool. DAVID uses GO and other data sources to cluster proteins based on the shared annotations to similarity clusters. DAVID analysis identified 3 significant annotation clusters (Table 2) , of which the highest ranked cluster had an enrichment score (ES) of 4.89 and was represented by 3 terms relating to mitochondrion.
The mitochondrial cluster accounted for 33% of the identified proteins and included:
ATP synthase subunit beta (Atp5b), Elongation factor G1 (EF-G1mt), Elongation factor G2 (EF- 
. These data suggest a significant decrease of mitochondrial activity and energy metabolism in the colonic mucosa during WAS. Invalidation of β2i expression alone induced similar modifications of colonic proteome except for Vsp4b, Atp5b and AK (Table 1) . Interestingly, Vsp4b, Atp5b and AK remained unaffected in β2i -/-WAS mice compared with β2i -/-control mice. In addition, in β2i -/-mice, WAS altered alpha-enolase-1 (ENO1), which was downregulated, and Uridine phosphorylase 1 (UPase 1; Table 1 ). By comparing the response of wt and β2i -/-mice to WAS, we observed a reduction of ENO1, HSP60 and GDH1 expression in β2i -/-WAS mice (Table 1 and Figure 3 ).
WAS and immunoproteasome subunit beta2i deficiency alter ubiquitin-proteasome
system in the colon.
We also observed that proteasome subunits were significantly enriched among identified proteins. The proteasome cluster (ES = 2.06, Table 2 ) was made up from three proteasome alpha subunits (PSMA3/4/5) and 26S protease regulatory subunit S10B (PSMC6). The expression levels of PSCM6 and two others UPS related-proteins, namely pre-mRNA-processing factor (Prpf19) and protein deglycase (DJ-1), were decreased in the colonic mucosa of wt mice during WAS ( Figure 4) . Interestingly, β2i -/-WAS mice exhibited an increased expression of PSMA3
and PSMA5 as compared to β2i -/-control mice, and of PSMA3, PSMA5 and UCH-L3 when compared to wt WAS mice (Table 1 and Figure 4 ). By contrast, PSMA4 were downregulated while Prpf19 and DJ-1 remained unaffected in β2i -/-WAS mice. UCH-L3 is a deubiquitinating enzyme (DUB) that controls levels of cellular ubiquitin through processing of ubiquitinated proteins. We thus evaluated the level of ubiquitinated proteins in the colonic mucosa and we observed that both wt and β2i -/-control mice exhibited a reduction of ubiquitinated protein levels in response to WAS ( Figure 2B ). Interestingly, β2i -/-WAS mice exhibited lower ubiquitinated protein level than wt WAS mice. All these data suggest that (i) WAS affected UPS and (ii) that subunit β2i deficiency may regulate the degradation of specific proteins.
Ubiquitination of inflammation-related proteins is modulated in the colonic mucosa of IBS-D patients
Because Interestingly, enrichment analysis of KEGG pathways in DAVID showed that A20, COX-2, IRF3 and TRAF6 were involved in the NF-κB signaling pathway (39.7-fold enrichment, p=0.031). All these data suggest that ubiquitination of these proteins may participate in the pathophysiology of IBS-D, which is commonly described as a low grade inflammatory state, by regulating apoptosis and disrupting UPS mechanism.
DISCUSSION
In the present study, we provide evidence that the ubiquitin-proteasome system contributes to the pathophysiology of IBS. Indeed, we report that colonic proteome is altered in stressed mice and that β2i subunit deficiency modifies the proteome response that is associated with a limitation of colonic hyperpermeability. Interestingly, we show specific alterations of proteins involved in UPS, mitochondrial and energy metabolism. We also report changes in the pattern of colonic ubiquitome in IBS-D patients, and particularly a reduced expression of ubiquitinated proteins involved in the NF-κB signaling pathway.
Previous studies clearly demonstrated that UPS may be involved in the regulation of inflammatory response 33 or gut barrier function 10 . We and others have reported the formation of an alternative proteasome called immunoproteasome in the colonic mucosa of IBS 10 and CD 15, 34 patients. It was also shown that proteasome composition and activity were different between CD and IBS patients. 10 Indeed, trypsin-like activity was increased in the colonic mucosa of IBS patients 35 but not in CD patients. By contrast, chymotrypsin-like activity remained unchanged in IBS patients whereas it was upregulated in CD patients. In the present study, we used a stress model (the water avoidance stress "WAS" model) able to reproduce certain aspects of IBS such as visceral hypersensibility or intestinal hyperpermeability. Indeed, stress contributes to the development and aggravation of IBS symptoms. 36 WAS mice exhibited an increase colonic permeability, trypsin-like activity and β2i/β2 subunit ratio, 21 that was previously observed in IBS-D patients. 10 In our study, we showed that β2i subunit deficiency increased expression of proteasome subunits (PSMA3/5) in stressed mice, whereas PSMA4 and ubiquitinated proteins was downregulated. The shift from constitutive to immunoproteasome could be responsible for 19 the decrease of ubiquitinated proteins after WAS since Seifert et al. showed that immunoproteasome activity is higher than constitutive proteasome activity. 37 Nevertheless, Nathan et al. have reported that immunoproteasomes and constitutive proteasomes degraded ubiquitinated proteins at similar rates following IFNγ-treatment. 38 Other processes like ubiquitination and deubiquitination may also be involved. UCH-L3, which was increased in β2i -/-mice in the present study, is a deubiquitinating enzyme performing hydrolysis of the bond at the C terminus of the ubiquitin and triming down the polyubiquitin chain into monomers. UCH-L3
knock-out mice led to marked accumulation of ubiquitinated proteins in the skeletal muscles. 39 However, the effect of UCH-L3 overexpression on ubiquitinated protein level remains unknown.
Thus, the underlying mechanisms responsible of the ubiqtuinated protein level changes need to be deeply explored. UCH-L3 also processed an ubiquitin-like substrate called NEDD8 and regulated smad1 ubiquitination in osteoblast differentiation. 40 induces ubiquitination and degradation of phosphorylated substrates including I-κB, the inhibitor of NF-κB. 46 Previous papers reported that NF-κB activity can also be limited by glutamine through the regulation of I-κB ubiquitination 29, 47 and particularly by the regulation of cullin-1 neddylation. 48 Interestingly, in the present study, we showed that β2i subunit deficiency leads to 20 a reduced expression of GDH1 in the colonic mucosa of WAS mice. GDH1 is a metabolic enzyme mainly located in the mitochondria that catalyzes the reversible NAD (P)+-linked oxidative deamination of glutamate into α-ketoglutarate and ammonia. This reaction is the final step of glutaminolysis after the conversion of glutamine to glutamate by glutaminase. In inflammatory experimental conditions, glutamine supplementation improves gut barrier function [49] [50] [51] [52] , regulates UPS 29, 48, 53 and restores colonic TJ protein expression. 49, 50, 54 We have recently demonstrated that glutamine supplementation prevented colonic hyperpermeability and reduced proinflammatory cytokine production in WAS mice. 21 Zhou et al. have recently reported that reduced expression of glutamine synthase in colon tissues of IBS-D patients may lead to decreased claudin-1 expression, and consequently increased intestinal permeability. 55 In the same way, we have shown ex vivo that glutamine supplementation increased claudin-1 expression in the colonic mucosa of IBS-D patients. 54 In a randomized controlled trial, Zhou et al recently showed the beneficial effect of glutamine supplementation on intestinal permeability and gastrointestinal symptoms in post-infectious IBS patients. 56 All these data are in accordance with previous studies showing that glutamine supplementation or deprivation is able to modify TJ protein expression and influence intestinal permeability. 50, 57 The mechanisms of action for glutamine remain not completely understood and have been previously discussed. 58, 59 In our model, we can thus speculate that immunoproteasome inhibition induces higher glutamine content and overexpression of UCH-L3 leading to limitation of inflammatory response and improved barrier function ( Figure 6 ). The assessment of colonic mucosal glutamine content in β2i -/-WAS mice should be thus further investigated.
To confirm the putative role of proteasome system in the pathophysiology of IBS, we have investigated in IBS-D patients the changes of ubiquitination rate of colonic proteins.
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Interestingly, we observed alterations of ubiquitome, and particularly a reduced expression of 7 ubiquitinated proteins involved in the NF-κB signaling pathway. Cleynen et al. previously reported that adherent-invasive Escherichia coli (AIEC) was able to regulate UPS leading to a decrease of NF-κB negative regulator CYLD in intestinal epithelial cells. 60 In patients with IBS-D, Zhou et al. recently underlined that colonic hyperpermeability caused by TNF-α may be due to activation of NF-kB expression and disassembly of claudin-1. 55 All of these data suggest potential relationship between UPS, glutamine content, inflammatory response and TJ protein expression in the pathophysiology of IBS. Further investigations should be done to deeply explore these mechanisms.
In conclusion, we provide evidence that (i) β2i subunit deficiency modified colonic UPS analysis and interpretation of the data.
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